A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, ...

Routine SLNB may be used to predict tumor invasion levels and SLN metastasis in patients with EMPD who do not have enlarged lymph nodes.

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

The efficacy and safety of efinaconazole 10% solution is acceptable among older adults with onychomycosis and comparable to the general population.

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

The FDA plans to approve selected high-priority drug application submissions in 1 to 2 months rather than 10 to 12.

Clay W. Walker, MPAS, PA-C, is an assistant professor of family medicine at the Mayo Clinic in Phoenix, Arizona. He has over 8 years of experience in primary care, internal medicine, and ...

By including information on suicidal thoughts and behaviors, clinicians can greatly improve predictive accuracy via machine learning.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.